Table 2.
Cost-effectiveness analysis for the comparison of PA vs B + P vs C + P a
| Investigation strategy | Cost [£] [97.5% CI]b | Incremental cost [£] [97.5% CI]b c |
Incidence [97.5% CI]b | Incremental incidence [97.5% CI]b c |
ICERc [£] |
|---|---|---|---|---|---|
| Incremental cost per incidence of dental pain and/or infection avoided | |||||
| PA (n = 354) | 206 [176 to 237] | 0.44 [0.39 to 0.50] | |||
| B + P (n = 352) | 226 [201 to 252] | 19 [−18 to 55] | 0.39 [0.33 to 0.45] | −0.058 [−0.14 to 0.02] | 328 |
| C + P (n = 352) | 245 [219 to 271] | 0.41 [0.35 to 0.47] | Dominated by B + P | ||
| Incremental cost per episode of dental pain and/or infection avoided | |||||
| Investigation strategy |
Cost [£] [97.5% CI]b |
Incremental cost [£] [97.5% CI]b c |
Episodes [97.5% CI]b |
Incremental episodes [97.5% CI]b c |
ICER c [£] |
| PA (n = 354) | 206 [176 to 237] | 0.70 [0.58 to 0.82] | |||
| B + P (n = 352) | 226 [201 to 252] | 19 [−18 to 55] | 0.56 [0.46 to 0.67] | −0.143 [−0.29 to 0.01] | 133 |
| C + P (n = 352) | 245 [219 to 271] | 0.60 [0.49 to 0.71] | Dominated by B + P | ||
a costs and effects are discounted at 3.5%; b 97.5% CI was used as it adjusts for multiple comparisons and should be interpreted as if it were a 95% CI; c estimated based on adjusted analysis (n = 1057; n = 1 child missing information on age); d ICER = incremental cost-effectiveness ratio